The impact of tendon and ligament disorders—such as tendinopathy, ligament sprain, overuse injury, and post-surgical tissue damage—is now widely observed in routine orthopedic and physical medicine practice. Radiant Nutraceuticals Limited has launched Tenolig™ EC Tablet from 4th January 2026 to address these tendon and ligament related conditions in a comprehensive manner.
Tenolig™ is a combination of Collagen Type-1, L-Arginine, Sodium Hyaluronate, Chondroitin Sulphate and Vitamin C & scientifically designed and well-tolerated formulation that supports tendon and ligament repair by improving structural integrity, reducing inflammation, and enhancing functional recovery. Tenolig™ plays a significant role in injury management as well as post-surgical rehabilitation in Tendinopathy & Ligament Injury, helping patients regain mobility and function safely and effectively.
12 January, 2026
